References
1. Gould MK. Prevention of VTE in Nonorthopedic Surgical Patients. CHEST J. 2012;141(2_suppl): e227S, Doi: 10.1378/chest.11-2297.
2. Guyatt GH., Akl EA., Crowther M., et al. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 SUPPL.):7-47, Doi: 10.1378/chest.1412S3.
3. Vandiver JW., Ritz LI., Lalama JT. Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations. J Thromb Thrombolysis. 2016;41(3):475-81, Doi: 10.1007/s11239-015-1231-5.
4. Espinet-Coll E., Nebreda-Durán J., Gómez-Valero JA., et al. Current endoscopic techniques in the treatment of obesity. Rev Esp Enferm Dig. 2012; 104:72-87, Doi: 10.4321/S1130-01082012000200006.
5. Llau Pitarch J.V., Arcelus Martínez J.I., Castellet Feliu E, et al. Recomendaciones de tromboprofilaxis en Cirugía Mayor Ambulatoria. Documento multidisciplinar de consenso de la Asociación Española de Cirugía Mayor Ambulatoria (ASECMA). CIR MAY AMB. 2016;21(1):25-36.
6. Jamal MH., Corcelles R., Shimizu H., et al. Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience. Surg Endosc. 2014;29(2):376-80, Doi: 10.1007/s00464-014-3678-4.
7. Genco A., López-Nava G., Wahlen C., et al. Multi-Centre european experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg. 2013;23(4):515-21, Doi: 10.1007/s11695-012-0829-3.
8. López-Nava G., Bautista-Castaño I., Jiménez A., et al. The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis. 2014;11(4):861-5, Doi: 10.1016/j.soard.2014.09.026.
9. López-Nava G., Galvao M., Bautista-Castaño I., et al. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int open. 2016;4(2): E222-7, Doi: 10.1055/s-0041-110771.
10. Vilarrasa N., de Gordejuela AGR., Casajoana A., et al. Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism. Obes Surg. 2017;27(3):569-77, Doi: 10.1007/s11695-016-2311-0.
11. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70:195e283.
12. Pories WJ, Van Rij AM, Burlingham BT, et al. Prophylactic cefazolin in gastric bypass surgery. Surgery. 1981; 90:426-32.
13. Preclik G, Grüne S, Leser HG, et al. Prospective, randomized, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ. 1999; 319:881-4.
14. Fischer MI, Dias C, Stein AT, et al. Antibiotic prophylaxis in obese patients submitted to bariatric surgery. A systematic review. Acta Cirúrgica Brasileira; 2014; 29 (3): 209-217.
15. Banerjee S, Shen B, Baron TH, for the American Society for Gastrointestinal Endoscopy Standards of Practice Committee. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008; 67:791-8.
16. Rey JR, Axone A, Budzynska A, et al. Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy. 1998; 30:318-24.
17. Christou NV, Jarand J, Sylvestre JL, et al. Analysis of the incidence and risk factors for wound infections in open bariatric surgery. Obes Surg. 2004; 14:16-22.
18. Uchiyama K, Takifuji K, Tani M, et al. Prevention of postoperative infections by administration of antimicrobial agents immediately before surgery for patients with gastrointestinal cancers. Hepatogastroenterology. 2007; 54:1487-93.
19. Anderson DJ, Podgorny K, Berrios-Torres SI, et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014; 35:605e627.
20. Steinberg JP, Braun BI, Hellinger WC, et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg 2009; 250:10e16.
21. Hawn MT, Richman JS, Vick CC, et al. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg 2013; 148:649e657.
22. Peppard William J., Eberle David G., Kugler Nathan W., et al. Association between Pre-Operative Cefazolin Dose and Surgical Site Infection in Obese Patients. Surg Infect. 2017 May/Jun;18(4):485-490. doi: 10.1089/sur.2016.182. Epub 2016 Dec 1.
23. El-Hayek K, Timratana P, Shimizu H, et al. Marginal ulcer after Roux-en-Y gastric bypass: what have we really learned ? Surg Endosc 2012; 26: 2789-96.
24. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient -- 2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013 Mar; 21 Suppl 1: S1-27.
25. Chan FK, Wong VW, Suen BY, et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet. 2007; 369:1621-6.
26. ASGE Standards of Practice Committee, Acosta RD, Abraham NS, Chandrasekhara V, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016; 83(1):3-16.
27. Gralnek IM, Dumonceau JM, Kuipers EJ, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 1–46.
28. Espinós JC, Turró R, Mata A, et al. Early experience with the Incisionless Operating Platform (IOP) for the treatment of obesity: the Primary Obesity Surgery Endolumenal (POSE) procedure. Obes Surg 2013; 23(9): 1375-83.
29. Espinet Coll E, Nebreda Durán J, López-Nava Breviere G, et al. Multicenter study on the safety of bariatric endoscopy. Rev Esp Enferm Dig. 2017; 109(5): 350-357.
30. López-Nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up. Obes Surg. 2017; 27(10): 2649-2655.
31. Kumar N, Thompson CC. Transoral outlet reduction for weight regain after gastric bypass: long-term follow-up. Gastrointest Endosc 2016; 83(4):776-9.
32. Thompson CC, Abu Dayyeh BK, Kushner K, et al. Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. Am J Gastroenterol. 2017; 112(3):447-457.
33. Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc 2010; 71(6): 976-82.
34. Abu-Dayyeh B. A randomized, multi-center study to evaluate the safety and effectiveness of the orbera intragastric balloon as an adjunct to a behavioral modification program. In: Comparison with a Behavioral Modification Program Alone in the Weight Management of Obese Subjects. Rochester, MN: Mayo Clinic; 2015 (Publication Pending). Online at: http://www.orbera.com/resource/1441904169000/o_orbera_code/pdf/ORBERA_Directions_for_Use_GRF-00346-00R01.pdf.)
35. Ponce J, Quebbemann BB, Patterson EJ. Prospective, randomized, multicenter study evaluating safety and efficacy of intragastric dual-balloon in obesity. Surg Obes Relat Dis 2013; 9(2): 290-5.
36. Larrad A, Sánchez-Cabezudo C. Indicadores de calidad en cirugía bariátrica y criterios de éxito a largo plazo. Cir Esp 2004; 75: 301-4.
37. Rubio MA, Martínez C, Vidal O, et al. Documento de consenso sobre cirugía bariátrica. Rev Esp Obes 2004; 4: 223-249.
38. Espinet Coll E, López-Nava Breviere G, Nebreda Durán J, et al. Documento español de consenso en endoscopia bariátrica. Parte 1. Consideraciones generales. Rev Esp Enferm Dig 2018;110(6): 386-399.
39. Bruguera M, Viger M, Bruguera R, et al. Reclamaciones por presunta negligencia relacionadas con endoscopia digestiva. Análisis de una casuística de 22 años. Gastroenterol Hepatol 2011; 34(4):248-253.
40. Ley 41/2002, de 14 de noviembre, Básica Reguladora de la Autonomía del Paciente y de Derechos y Obligaciones en Materia de Información y Documentación Clínica. Boletín Oficial del Estado, núm. 274 de 15 de noviembre de 2002. p. 40126-132.
41. García Ruiz De Gordejuela A, Madrazo González Z, Casajoana Badia A, et al. Descripción de la asistencia en urgencias de pacientes intervenidos de cirugía bariátrica en un centro de referencia. Rev Esp Enferm Dig 2015; 107: 23-28.
42. Brethauer SA, Chand B, Schauer PR. American Society for Metabolic and Bariatric Surgery (ASMBS) Centers of Excellence Program. In: Nguyen NT, Maria EJ, Ikramuddin S, Hutter MM, editors. The SAGES manual. New York: Springer; 2008. p. 257–60.
43. American Society for Gastrointestinal Endoscopy: establishment of gastrointestinal endoscopy areas. Gastrointest Endosc 1999; 50: 910–2.
44. American Society for Gastrointestinal Endoscopy: role of endoscopy in the bariatric surgery patient. Gastrointest Endosc 2008; 68: 1–10.
45. Dolz Abadía C, de Lorenzo Aparici O. Aspectos médico-legales de la endoscopia digestiva. Congreso de la SEED. Zaragoza 2015. Rev Esp Enferm Dig 2016; 108(2): 4-7.
46. Dolz Abadía C. Consentimiento informado en endoscopia digestiva: información para el paciente, protección para el endoscopista. Rev Esp Enferm Dig 2016; 108 (2): 13-23.
47. Kvitko LA. Rev Lat Der Med Legal 2002; 7:77-80.
48. Andreu E, Azparren A, Donat E. Estudio jurisprudencial en medicina satisfactiva. Rev Esp Med Legal 2001; 39:162-7.
49. Nebreda J, Espinet E, GETTEMO. Posicionamiento de GETTEMO sobre las técnicas endoscópicas bariátricas consideradas como medicina satisfactiva. Rev Esp Enferm Dig 2017; 109 (12): 875-876.
50. Vila JJ, Jiménez FJ, Iñarrairaegui M, et al. Informed consent document in gastrointestinal endoscopy: Understanding and acceptance by patients. Rev Esp Enferm Dig 2006; 98:101-11.